Nexgel (NXGLW) Return on Sales (2018 - 2025)

Nexgel has reported Return on Sales for 8 years, with the latest figure at 0.0% in Q4 2025.

• For the quarter ending Q4 2025, Return on Sales changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Dec 2025 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Sales for Q4 2025 stood at 0.0%, down from 0.0% in the prior quarter.
• The five-year high for Return on Sales was 0.0% in Q3 2025, with the low at 0.05% in Q1 2022.
• Historically, Return on Sales has averaged 0.01% across 5 years, with a median of 0.01% in 2024.
• Annual changes were most pronounced in 2021 — Return on Sales increased 4 bps — and 2022, when it fell 2 bps.
• Nexgel's Return on Sales stood at 0.03% in 2021, then soared by 63 bps to 0.01% in 2022, then advanced by 11 bps to 0.01% in 2023, then soared by 75 bps to 0.0% in 2024, then decreased by 22 bps to 0.0% in 2025.
• The last three Return on Sales figures came in at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.